Explore our

BioLizard is proud to be part of Ghent’s vibrant healthtech cluster, highlighted in Labiotech. The article showcases the city’s thriving biotech, medtech, and digital health ecosystem, where seamless collaboration drives innovation and supports cutting-edge life sciences research.

BioLizard hosted the Bits in Bio Belgium meeting, bringing together 50+ attendees to explore AI and machine learning in life sciences. Talks highlighted data governance, pipeline optimization, and interactive ML tools, fostering networking and collaboration across the scientific community.

At Knowledge for Growth, BioLizard’s Volodimir Olexiouk joined a panel on AI in life sciences. Discussions focused on AI tools, success stories, pitfalls, and accelerating drug discovery, highlighting the need for both advanced AI and expert human guidance to maximize impact in biotech pipelines.

BioLizard collaborated with Pierre Fabre Group to develop a user-friendly app for colorectal cancer patients, empowering them to manage their health. From concept to launch, the app reflects BioLizard’s vision of leveraging data to improve patient outcomes and quality of life.

BioLizard partners with Scaler8’s Explore Programme to expand into the US market. Leveraging Scaler8’s expertise and network, BioLizard aims to unlock new opportunities in biomedical and translational research, bringing advanced computational and predictive biological modeling to US clients.

BioLizard appoints three new independent board members, Caroline Vanovermeire, André van de Sande, and Laurie Heilmann, to strengthen strategic direction, operational growth, and global competitiveness. Their expertise spans leadership, life sciences, and data-driven drug discovery innovation.

BioLizard appoints Paul Vauterin as Chief Technology Officer to strengthen its leadership team. With deep expertise in data analytics and software architecture for life sciences, Paul will help BioLizard advance data-driven R&D, digital transformation, and innovative solutions for biotech and pharma.

BioLizard CEO Liesbeth Ceelen was named one of Belgium’s Top Fifty Women in Tech 2022 by InspiringFifty. With a PhD in veterinary sciences, she has driven BioLizard’s growth and champions women in tech, inspiring the next generation of leaders through her work and mentorship.